Quanterix Corporation Other Current Liabilities
Quanterix Corporation (QTRX) had Other Current Liabilities of $291.00 thousand as of 2023-03-31, per its 10-K/A filed 2024-12-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-12-26
- 2023-03-31: Other Liabilities, Current $291.00K.
- 2022-12-31: Other Liabilities, Current $386.00K.
- 2022-09-30: Other Liabilities, Current $268.00K.
- 2022-06-30: Other Liabilities, Current $396.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2023-03-31 | $291.00K 10-K/A · filed 2024-12-26 |
| 2022-12-31 | $386.00K 10-Q · filed 2023-05-09 |
| 2022-09-30 | $268.00K 10-K/A · filed 2024-12-26 |
| 2022-06-30 | $396.00K 10-K/A · filed 2024-12-26 |
| 2022-03-31 | $268.00K 10-K/A · filed 2024-12-26 |
| 2021-12-31 | $241.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.21M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.62M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.99M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.05M 10-K · filed 2022-03-01 |
| 2020-09-30 | $212.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $299.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $184.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $216.00K 10-K · filed 2021-03-05 |
| 2019-09-30 | $204.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $78.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $26.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |